|
Venmax Drugs & Pharmaceuticals Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
14.56 Cr.
|
P/BV
|
-22.06
|
Book Value (Rs.)
|
-1.26
|
|
52 Week High/Low (Rs.)
|
37/9
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
21/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 2.53 | 0.53 | 0.28 | 0.00 | 0.00 |
| Total Income From Operations | 2.53 | 0.53 | 0.28 | 0.00 | 0.00 |
| Purchase of Traded Goods | 3.71 | 0.55 | 0.30 | 0.00 | 0.00 |
| Increase/Decrease in Stocks | -1.47 | -0.06 | 0.00 | 0.00 | 0.00 |
| Employees Cost | 0.11 | 0.04 | 0.00 | 0.01 | 0.01 |
| Other Expenses | 0.10 | 0.74 | 0.29 | 0.04 | 0.04 |
| Total Expenses | 2.45 | 1.28 | 0.60 | 0.05 | 0.06 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 0.08 | -0.74 | -0.32 | -0.05 | -0.06 |
| Other Income | 0.00 | 1.02 | 0.03 | 0.15 | 0.05 |
| P/L Before Interest, Excpt. Items & Tax | 0.08 | 0.28 | -0.29 | 0.10 | -0.01 |
| P/L Before Exceptional Items & Tax | 0.08 | 0.28 | -0.29 | 0.10 | -0.01 |
| P/L Before Tax | 0.08 | 0.28 | -0.29 | 0.10 | -0.01 |
| Tax | 0.02 | 0.00 | 0.00 | 0.02 | 0.00 |
| P/L After Tax from Ordinary Activities | 0.06 | 0.28 | -0.29 | 0.07 | -0.01 |
| Net Profit/Loss For the Period | 0.06 | 0.28 | -0.29 | 0.07 | -0.01 |
| | | | | | |
| Equity Share Capital | 8.01 | 5.24 | 5.24 | 5.24 | 5.24 |
| Reserves And Surplus | 0.00 | 0.00 | 0.00 | -5.89 | 0.00 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 0.12 | 0.54 | -0.56 | 0.14 | -0.02 |
| Diluted EPS (Rs.) | 0.12 | 0.53 | -0.56 | 0.13 | -0.02 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 0.12 | 0.54 | -0.56 | 0.14 | -0.02 |
| Diluted EPS (Rs.) | 0.12 | 0.00 | -0.56 | 0.00 | -0.02 |
| | | | | | |
| PBITOE Margin (%) | 3.29 | -139.79 | -117.21 | N.A | N.A |
| PBTE Margin (%) | 3.26 | 52.53 | -106.61 | N.A | N.A |
| PBT Margin (%) | 3.26 | 52.53 | -106.61 | N.A | N.A |
| PAT Margin (%) | 2.44 | 53.19 | -106.64 | N.A | N.A |
